Targeted therapy for head and neck cancer: signaling pathways and clinical studies

Q Li, Y Tie, A Alu, X Ma, H Shi - Signal transduction and targeted …, 2023 - nature.com
Head and neck cancer (HNC) is malignant, genetically complex and difficult to treat and is
the sixth most frequent cancer, with tobacco, alcohol and human papillomavirus being major …

Immunotherapy and biomarker testing in recurrent and metastatic head and neck cancers: ASCO guideline

E Yilmaz, N Ismaila, JE Bauman, R Dabney… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To provide evidence-based recommendations for practicing physicians and
other health care providers on immunotherapy and biomarker testing for head and neck …

Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single …

L Yuan, GD Jia, XF Lv, SY **e, SS Guo, DF Lin… - Nature …, 2023 - nature.com
Immunotherapy combined with antiangiogenic targeted therapy has improved the treatment
of certain solid tumors, but effective regimens remain elusive for refractory …

Analytical validation of NavDx, a cfDNA-based fragmentomic profiling assay for HPV-driven cancers

A Gunning, S Kumar, CK Williams, BM Berger… - Diagnostics, 2023 - mdpi.com
The NavDx® blood test analyzes tumor tissue modified viral (TTMV)-HPV DNA to provide a
reliable means of detecting and monitoring HPV-driven cancers. The test has been clinically …

Current perspectives on recurrent HPV-mediated oropharyngeal cancer

T Guo, SY Kang, EEW Cohen - Frontiers in Oncology, 2022 - frontiersin.org
In the recent years, the prevalence of HPV-positive oropharyngeal squamous cell carcinoma
(OPSCC) has increased significantly. Currently, nearly 80-90% of all oropharynx tumors are …

Combination therapy as a promising way to fight oral cancer

JPN Silva, B Pinto, L Monteiro, PMA Silva, H Bousbaa - Pharmaceutics, 2023 - mdpi.com
Oral cancer is a highly aggressive tumor with invasive properties that can lead to metastasis
and high mortality rates. Conventional treatment strategies, such as surgery, chemotherapy …

Circulating tumor HPV DNA for surveillance of HPV-positive oropharyngeal squamous cell carcinoma: A narrative review

KAL Kuhs, JC Brenner, FC Holsinger… - JAMA oncology, 2023 - jamanetwork.com
Importance Human papillomavirus (HPV)–positive oropharyngeal squamous cell carcinoma
has an overall favorable prognosis, yet a subset of patients will experience devastating …

Characterization of immune microenvironment in patients with HPV-positive and negative head and neck cancer

Z Wang, Q Wang, Y Tao, J Chen, Z Yuan, P Wang - Scientific Data, 2023 - nature.com
Human papillomavirus (HPV) status strongly predicts positive clinical outcomes in patients
with head and neck squamous cell cancer (HNSCC); however, the potential reasons have …

Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment

LM Cao, NN Zhong, Y Chen, ZZ Li, GR Wang, Y **ao… - Cancer Letters, 2024 - Elsevier
Head and neck squamous cell carcinoma (HNSCC) constitutes a significant global cancer
burden, given its high prevalence and associated mortality. Despite substantial progress in …

Cinnamomum zeylanicum Extract and its Bioactive Component Cinnamaldehyde Show Anti-Tumor Effects via Inhibition of Multiple Cellular Pathways

S Aggarwal, K Bhadana, B Singh, M Rawat… - Frontiers in …, 2022 - frontiersin.org
Cinnamomum zeylanicum is a tropical plant with traditional medicinal significance that
possesses antimicrobial, antifungal, anti-parasitic, and anti-tumor properties. Here, we have …